Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
A Comprehensive Review of Roxadustat's R&D Innovations and Drug Target Mechanism
10 October 2023
This article summarized the latest R&D progress of Roxadustat, the Mechanism of Action for Roxadustat, and the drug target R&D trends for Roxadustat.
Latest Hotspot
3 min read
Amicus Therapeutics Declares FDA Sanction and Introduction of Novel Therapy for Pompe Disease
10 October 2023
Amicus Therapeutics has confirmed that the U.S. FDA has given the green light to Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) 65mg capsules.
Drug Insights
4 min read
Pharmaceutical Insights: Rufinamide's R&D Progress and its Mechanism of Action on Drug Target
10 October 2023
This article summarized the latest R&D progress of Rufinamide, the Mechanism of Action for Rufinamide, and the drug target R&D trends for Rufinamide.
Valuable Targets
5 min read
Advances in Clinical Research on Leukotriene Receptor Antagonist
10 October 2023
CysLT, or cysteinyl leukotrienes, are inflammatory mediators produced by various cells in the human body, including mast cells, eosinophils, and macrophages.
Drug Insights
4 min read
Exploring Selinexor's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
10 October 2023
This article summarized the latest R&D progress of Selinexor, the Mechanism of Action for Selinexor, and the drug target R&D trends for Selinexor.
Latest Hotspot
3 min read
IASO Bio showcases Updated Long-Term Follow-Up information for BCMA CAR-T FUCASO®
10 October 2023
These studies focused on the outcomes of the Phase 1b/2 study carried out on patients who had relapsed/refractory multiple myeloma and were undergoing treatment with Equecabtagene Autoleucel.
Drug Insights
4 min read
Decoding Terbinafine hydrochloride: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
10 October 2023
This article summarized the latest R&D progress of Terbinafine hydrochloride, the Mechanism of Action for Terbinafine hydrochloride, and the drug target R&D trends for Terbinafine hydrochloride.
Advanced Tech.
5 min read
The "Antidote" Specific to Biological Toxins: Antitoxin
10 October 2023
Antitoxin is a specific antibody or serum containing this antibody that can neutralize toxins. By using toxoids for immunization, the body can produce corresponding antitoxins to prevent diseases.
Drug Insights
4 min read
Deep Scientific Insights on Thiothixene's R&D Progress, Mechanism of Action, and Drug Target
10 October 2023
This article summarized the latest R&D progress of Thiothixene, the Mechanism of Action for Thiothixene, and the drug target R&D trends for Thiothixene.
Latest Hotspot
3 min read
Mabwell Discloses Initial Patient Treatment in Phase Ib/II Study for Nectin-4 Focused ADC coupled with PD-1 Inhibitor
10 October 2023
Mabwell announced the initiation of a Phase Ib/II trial with the first patient dosage. The study uses their novel Nectin-4 ADC (9MW2821) in conjunction with a PD-1 inhibitor for advanced or metastatic urothelial carcinoma.
Drug Insights
4 min read
An In-depth Analysis of Tigecycline's R&D Progress and Mechanism of Action on Drug Target
10 October 2023
This article summarized the latest R&D progress of Tigecycline, the Mechanism of Action for Tigecycline, and the drug target R&D trends for Tigecycline.
Valuable Targets
5 min read
Analysis on the Clinical Research Progress of Myostatin inhibitors
10 October 2023
Myostatin, a member of the transforming growth factor beta (TGF‐β) superfamily that is highly expressed in skeletalmuscle, was first described in 1997.